Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Novo Nordisk Addresses Innovation in Diabetes Care in Second Issue of Industry Resource for Information on Diabetes and Chronic Disease

July 12, 2010 11:37 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J. , July 12 /- Novo Nordisk Inc., a global healthcare company and leader in diabetes care, today announced the second issue of the Novo Nordisk BlueSheet, a resource for information on diabetes and chronic disease, highlighting key issues in diabetes prevention, detection,...

TOPICS:

B. Braun Large Volume Heparin Infusion Solutions Now Available

July 12, 2010 11:37 am | by Bio-Medicine.Org | News | Comments

BETHLEHEM, Pa. , July 12 /- B. Braun Medical Inc. (B. Braun) announced today the availability of large volume heparin infusion solutions. (Logo:   http://photos.prnewswire.com/prnh/20081022/NYW008LOGO ) (Logo:   http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO )...

TOPICS:

BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update

July 12, 2010 11:37 am | by Bio-Medicine.Org | News | Comments

LYNBROOK, N.Y. , July 12 /- BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical company developing first in class collagenase-based products, today announced that its strategic partner Auxilium Pharmaceuticals, Inc. has provided an update on XIAFLEX, its injectable...

TOPICS:
Advertisement

Ferring Pharmaceuticals' FIRMAGON® Named Official Sponsor of Ed Randall's Bat for the Cure

July 12, 2010 11:37 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J. , July 12 /- Ferring Pharmaceuticals Inc., the makers of FIRMAGON® (degarelix for injection), will sponsor Ed Randall 's Bat for the Cure charity, in an effort to "strike-out prostate cancer" with awareness, education, effective management and prevention support at...

TOPICS:

Hanger Ivan R. Sabel Foundation to Receive $75,000 Donation Towards Charitable Prosthetic Efforts in Haiti from Grapes for Humanity/US

July 12, 2010 11:37 am | by Bio-Medicine.Org | News | Comments

BETHESDA, Md. , July 12 /- The Hanger Ivan R. Sabel Foundation today announced it will receive a generous donation of $75,000 from Grapes for Humanity/US, an internationally recognized charitable foundation that has raised millions of dollars in support of landmine survivors and innocent...

TOPICS:

DocNog California Mobile App Automates Medical Provider Search

July 12, 2010 11:37 am | by Bio-Medicine.Org | News | Comments

MURRIETA, Calif. , July 12 /- NogWorld LLC, a pioneer in mobile search technology, has launched DocNog, a mobile app designed to empower healthcare consumers to easily connect and access medical providers. The DocNog California App was recently featured in the "New and Noteworthy" section...

TOPICS:

Holon: The Process Adaptive Interoperability Framework

July 12, 2010 11:37 am | by Bio-Medicine.Org | News | Comments

ATLANTA , July 12 /- Holon, the new standard for healthcare interoperability, today announced general availability of its Medication Management solution. Leveraging the Holon Process Adaptive Interoperability Framework, Holon introduces a cost-effective alternative to your paper processes...

TOPICS:

Early diagnosis key in managing, treating bladder cancer

July 12, 2010 11:36 am | by Baylor College of Medicine | News | Comments

Early diagnosis of bladder cancer is critical to management and treatment of the disease and improving chances of survival, said a urologic oncologist from Baylor College of Medicine . "Bladder cancer is a highly treatable, highly curable disease particularly before it invades the...

TOPICS:
Advertisement

BCM researchers leading efforts in bladder cancer research

July 12, 2010 11:36 am | by Baylor College of Medicine | News | Comments

Researchers from Baylor College of Medicine's Scott Department of Urology , Department of Molecular and Cellular Biology and the NCI-designated Dan L. Duncan Cancer Center are leading major efforts in bladder cancer research, both in the clinical and lab setting. Find out more about...

TOPICS:

Older men with smoking history needed for bladder cancer screening study

July 12, 2010 11:36 am | by Baylor College of Medicine | News | Comments

Men over the age of 60 who have smoked for at least 20 years are being asked to participate in a bladder cancer screening study at Baylor College of Medicine . Currently, there is no established screening method for bladder cancer. "We want to find a way to detect the cancer early enough...

TOPICS:

Telik Announces Publication of Review Focused on the Inhibition of the Enzyme GSTP1-1 as a Target for New Cancer Treatments

July 12, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif. , July 12 /- Telik, Inc. (Nasdaq: TELK ) today announced the publication of a review in the journal, Cell Death and Differentiation : Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death;...

TOPICS:

Novelos revives failed drug as potential breast cancer treatment

July 12, 2010 11:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Novelos Therapeutics Inc. has announced positive Phase 2 results for NOV-002 to treat patients with certain types of breast cancer, following an earlier failure of the drug target to treat lung cancer.

TOPICS:

Lantheus Medical acquires global rights to ex-Epix product

July 12, 2010 11:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Diagnostic imaging firm Lantheus Medical Imaging Inc. has acquired global rights to Ablavar, a blood pool imaging agent used in patients with peripheral vascular disease and formerly owned by now-bankrupt Epix Pharmaceuticals Inc.

TOPICS:

Compliance Corner: As Good as Your Suppliers—Watch Out!

July 12, 2010 11:08 am | by Ken Appel | Blogs | Comments

To maintain the modicum of quality standards, many are re-discovering the reasons why the Japanese auto industry pioneered poka-yoke assembly techniques years ago—where extra steps are built into manufacturing processes to take the potential for errors by less-trained workers out of the equation.

Supreme Court Decision Could Help Protect Patents for Diagnostics

July 12, 2010 8:31 am | by U.S. Food & Drug Administration | News | Comments

Diagnostic companies seeking to patent a process or method used in product development may have an easier time doing so following a recent Supreme Court decision.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading